US Stock MarketDetailed Quotes
ACTU Actuate Therapeutics
- 8.930
- -0.030-0.33%
Trading Nov 19 13:26 ET
174.42MMarket Cap-6129P/E (TTM)
9.050High8.670Low36.84KVolume8.840Open8.960Pre Close324.70KTurnover1.32%Turnover RatioLossP/E (Static)19.53MShares10.16252wk High32.59P/B25.00MFloat Cap5.51052wk Low--Dividend TTM2.80MShs Float10.162Historical High--Div YieldTTM4.24%Amplitude5.510Historical Low8.814Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Actuate Therapeutics Stock Forum
CHICAGO and FORT WORTH, Texas, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers through the inhibition of glycogen synthase kinase-3 beta (GSK-3β), announced that it will participate in “Webinar Wednesday” hosted b...
No comment yet